Search research articles
Contact Us
Filters
Showing results (71-80 of 75) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 75 results.
BMJ Open
|
July 1, 2021
SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials
Melanie Calvert, Madeleine King, Rebecca Mercieca-Bebber, et al.
Nature Medicine
|
February 29, 2024
Recommendations to address respondent burden associated with patient-reported outcome assessment
Olalekan Lee Aiyegbusi, Samantha Cruz Rivera, Jessica Roydhouse, et al.
The Lancet. Haematology
|
April 28, 2022
Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies
Gita Thanarajasingam, Lori M Minasian, Vishal Bhatnagar, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer
Elaine Chang, Noah M Hahn, Seth P Lerner, et al.
The Lancet. Oncology
|
November 27, 2025
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials
Cecilie D Amdal, Ragnhild S Falk, Ahu Alanya, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 75) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 75 results.
BMJ Open
|
July 1, 2021
SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials
Melanie Calvert, Madeleine King, Rebecca Mercieca-Bebber, et al.
Nature Medicine
|
February 29, 2024
Recommendations to address respondent burden associated with patient-reported outcome assessment
Olalekan Lee Aiyegbusi, Samantha Cruz Rivera, Jessica Roydhouse, et al.
The Lancet. Haematology
|
April 28, 2022
Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies
Gita Thanarajasingam, Lori M Minasian, Vishal Bhatnagar, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer
Elaine Chang, Noah M Hahn, Seth P Lerner, et al.
The Lancet. Oncology
|
November 27, 2025
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials
Cecilie D Amdal, Ragnhild S Falk, Ahu Alanya, et al.
Page
of 8